Phase III trial of alpha-1 antitrypsin (AAT) in patients with graft-versus-host disease

Trial Profile

Phase III trial of alpha-1 antitrypsin (AAT) in patients with graft-versus-host disease

Planning
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2015

At a glance

  • Drugs Alpha 1-antitrypsin (Primary)
  • Indications Graft-versus-host disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Kamada
  • Most Recent Events

    • 25 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top